What are the next steps for treating insomnia after Ambien (zolpidem) and Belsomra (suvorexant) have proven ineffective?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

When Ambien (zolpidem) and Belsomra (suvorexant) are no longer effective for treating insomnia, the most recommended next step is to consider Cognitive Behavioral Therapy for Insomnia (CBT-I) as a first-line treatment, as it has been shown to improve global outcomes and sleep quality in adults with chronic insomnia disorder 1.

Treatment Options

Other treatment options to consider include:

  • Trying other prescription medications like Lunesta (eszopiclone) at 1-3mg, which has been shown to improve short-term global and sleep outcomes compared with placebo 1
  • Dayvigo (lemborexant) at 5-10mg, which works on orexin receptors differently than Belsomra
  • Trazodone at 25-100mg before bedtime, although evidence for its effectiveness is limited

Non-Medication Approaches

In addition to medication, it is essential to improve sleep hygiene by:

  • Maintaining consistent sleep-wake times
  • Avoiding screens before bed
  • Limiting caffeine and alcohol
  • Creating a cool, dark sleeping environment

Further Evaluation

If these approaches fail, a comprehensive sleep study may be necessary to identify underlying conditions like sleep apnea or restless leg syndrome. A sleep specialist can help determine the most appropriate treatment based on your specific insomnia pattern and medical history.

Key Considerations

It is crucial to weigh the benefits and harms of pharmacologic treatments, as they may cause cognitive and behavioral changes, including driving impairment, and other adverse effects 1. CBT-I, on the other hand, has been shown to have mild or no harms associated with it 1.

From the Research

Next Steps for Treating Insomnia

After Ambien (zolpidem) and Belsomra (suvorexant) have proven ineffective, the next steps for treating insomnia may include:

  • Considering alternative pharmacological treatments, such as ramelteon, a selective melatonin receptor agonist, which has been shown to improve sleep quality and reduce sleep latency 2, 3
  • Implementing behavioral interventions, such as cognitive behavioral therapy for insomnia (CBT-I), which can help address underlying sleep habits and patterns
  • Improving sleep hygiene practices, such as establishing a consistent sleep schedule, creating a relaxing sleep environment, and avoiding stimulating activities before bedtime
  • Managing psychological stressors, such as anxiety and depression, which can contribute to insomnia

Alternative Treatment Options

Some alternative treatment options for insomnia include:

  • Ramelteon, which has been shown to be effective in reducing sleep latency and improving sleep quality, with a low risk of adverse events 2, 3
  • Other non-benzodiazepine hypnotics, such as eszopiclone and zaleplon, which may be considered as alternative treatment options
  • Melatonin receptor agonists, such as tasimelteon, which may be effective in treating insomnia, particularly in patients with circadian rhythm disorders

Important Considerations

When considering alternative treatment options, it is essential to:

  • Consult with a healthcare professional to determine the best course of treatment
  • Carefully evaluate the potential benefits and risks of each treatment option
  • Monitor treatment response and adjust the treatment plan as needed
  • Consider the potential for rebound insomnia and other adverse effects when discontinuing or switching treatments, as seen with zolpidem 4, 5

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.